Cardiac tamponade induced by dabrafenib and trametinib combination therapy for melanoma
Sign Up to like & getrecommendations! Published in 2018 at "Medicine"
DOI: 10.1097/md.0000000000012751
Abstract: Rationale: BRAF and MEK inhibitors (BRAF/MEKi) are targeted therapy for proto-oncogene BRAF mutated metastatic unresectable melanoma. Compared to monotherapy, an increased cardiovascular toxicity is reported with the combination of Dabrafenib and Trametinib. This case report… read more here.
Keywords: treatment; tamponade induced; therapy; tamponade ... See more keywords